What is the projected market valuation for the France extracorporeal membrane-oxygenation-machine market in 2035?

The projected market valuation for 2035 is $154.99 Million. Read More

What was the overall market valuation in 2024?

The overall market valuation was $83.86 Million in 2024. Read More

Which application segment is expected to show the highest growth in the market?

The Cardiac Support application segment is expected to grow from $30.0 Million to $55.0 Million. Read More

What are the key players in the France extracorporeal membrane-oxygenation-machine market?

Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices. Read More

How does the market for Venovenous ECMO compare to other product types?

The Venovenous ECMO product type is projected to grow from $35.0 Million to $65.0 Million, indicating strong demand. Read More

What is the expected market size for hospitals as an end user in 2035?

The expected market size for hospitals as an end user is projected to reach $90.0 Million by 2035. Read More

What is the valuation range for Blood Pumps in the component segment?

The valuation range for Blood Pumps in the component segment is from $25.0 Million to $45.0 Million. Read More

What is the anticipated growth for Home Care Settings in the end user segment?

Home Care Settings are expected to grow from $13.86 Million to $24.99 Million by 2035. Read More

Which component is projected to have the highest valuation in 2035?

The Membrane Oxygenator component is projected to have a valuation range of $30.0 Million to $55.0 Million. Read More

France Extracorporeal Membrane Oxygenation Machine Market

Q: What is the expected CAGR for the France extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 5.74%. Read More

ID: MRFR/MED/49073-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

France Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) andBy Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035

France Extracorporeal Membrane Oxygenation Machine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.74%

2024 Market Size$ 83.86 Million

2025 Market Size$ 88.67 Million

2035 Market Size$ 154.99 Million

Key Players

Medtronic

Getinge

LivaNova

Fresenius SE

Terumo Corporation

Maquet

Trends

Technological Advancements
Regulatory Support
Training and Education Initiatives

Opportunities

Advancements in Medical Technology
Government Initiatives and Funding
Rising Awareness and Training Programs

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Million) | |
  1. 4.1.1 Cardiac Support | |
  2. 4.1.2 Respiratory Support | |
  3. 4.1.3 Cardiopulmonary Bypass |
2. 4.2 Healthcare, BY End User (USD Million) | |
  1. 4.2.1 Hospitals | |
  2. 4.2.2 Ambulatory Surgical Centers | |
  3. 4.2.3 Home Care Settings |
3. 4.3 Healthcare, BY Product Type (USD Million) | |
  1. 4.3.1 Venoarterial ECMO | |
  2. 4.3.2 Venovenous ECMO | |
  3. 4.3.3 Arteriovenous ECMO |
4. 4.4 Healthcare, BY Component (USD Million) | |
  1. 4.4.1 Membrane Oxygenator | |
  2. 4.4.2 Blood Pumps | |
  3. 4.4.3 Heat Exchangers 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Getinge (SE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 LivaNova (GB) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Fresenius SE (DE) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Terumo Corporation (JP) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Maquet (DE) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Nipro Corporation (JP) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Cleveland Medical Devices (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION |
6. 6.3 FRANCE MARKET ANALYSIS BY END USER |
7. 6.4 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
8. 6.5 FRANCE MARKET ANALYSIS BY COMPONENT |
9. 6.6 KEY BUYING CRITERIA OF HEALTHCARE |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF HEALTHCARE |
12. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
14. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE |
15. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 HEALTHCARE, BY END USER, 2024 (% SHARE) |
18. 6.15 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million) |
19. 6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
20. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million) |
21. 6.18 HEALTHCARE, BY COMPONENT, 2024 (% SHARE) |
22. 6.19 HEALTHCARE, BY COMPONENT, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY END USER, 2025-2035 (USD Million) | |
  3. 7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  4. 7.2.4 BY COMPONENT, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

France Extracorporeal Membrane Oxygenation Machine Market Segmentation

France Extracorporeal Membrane Oxygenation Machine Market By Application (USD Million, 2025-2035)

Cardiac Support
Respiratory Support
Cardiopulmonary Bypass

France Extracorporeal Membrane Oxygenation Machine Market By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Home Care Settings

France Extracorporeal Membrane Oxygenation Machine Market By Product Type (USD Million, 2025-2035)

Venoarterial ECMO
Venovenous ECMO
Arteriovenous ECMO

France Extracorporeal Membrane Oxygenation Machine Market By Component (USD Million, 2025-2035)

Membrane Oxygenator
Blood Pumps
Heat Exchangers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035